Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

PDF +
Supplementary
Material

Hepatology

Original research

Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance

Online download statistics by month:

Online download statistics by month: November 2020 to November 2021

	Abstract	Full	Pdf
Nov 2020	86	85	13
Dec 2020	727	717	474
Jan 2021	355	345	193
Feb 2021	158	153	108
Mar 2021	146	142	144
Apr 2021	98	93	77
May 2021	160	158	93
Jun 2021	151	151	103
Jul 2021	128	126	80
Aug 2021	110	107	78
Sep 2021	140	132	353
Oct 2021	656	658	247
Nov 2021	322	316	159
Total	3237	3183	2122